Time-driven activity-based costing of a novel form of CT-guided high-dose-rate brachytherapy intraoperative radiation therapy compared with conventional breast intraoperative radiation therapy for early stage breast cancer

Intraoperative radiation therapy is an emerging option for adjuvant therapy for early stage breast cancer, although it is not currently considered standard of care in the United States. We applied time-driven activity-based costing to compare two alternative methods of breast intraoperative radiation therapy, including treatment similar to the techniques employed in the TARGIT-A clinical trial and a novel version with CT-guidance and high-dose-rate (HRD) brachytherapy.

Source: Brachytherapy - March 27, 2020 Category: Cancer & Oncology Authors: Greg Suralik, Sonali Rudra, Sunil W. Dutta, Jialu Yu, Jason C. Sanders, Michael D. Schad, Einsley-Marie Janowski, Lucy Su, Bruce Libby, Shayna L. Showalter, Jennifer M. Lobo, Timothy N. Showalter Source Type: research